InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Friday, 07/29/2016 1:33:21 PM

Friday, July 29, 2016 1:33:21 PM

Post# of 48316
Merck reported positive earnings today. Keytruda will be a huge growth driver for them in the years to come. Any positive combination trials with Keytruda such as the one ongoing with Oncosec will translate into higher share prices for both companies stock....plus help cure the millions of cancer patients not even diagnosed yet. We need continued innovation in the oncology field like what is happening at Merck and Oncosec.